These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 9687333)

  • 21. Analysis of the thymidine kinase of a herpes simplex virus type 1 isolate that exhibits resistance to (E)-5-(2-bromovinyl)-2'-deoxyuridine.
    Wilber BA; Docherty JJ
    J Gen Virol; 1994 Jul; 75 ( Pt 7)():1743-7. PubMed ID: 8021603
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Formulation, Optimization and Evaluation of Organogel for Topical Delivery of Acyclovir.
    Bonde S; Mavani N; Bonde C
    Curr Drug Deliv; 2018; 15(3):397-405. PubMed ID: 29034838
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selective enhancement of radiation response of herpes simplex virus thymidine kinase transduced 9L gliosarcoma cells in vitro and in vivo by antiviral agents.
    Kim JH; Kim SH; Kolozsvary A; Brown SL; Kim OB; Freytag SO
    Int J Radiat Oncol Biol Phys; 1995 Nov; 33(4):861-8. PubMed ID: 7591895
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Different in vitro effects of dual combinations of anti-herpes simplex virus compounds.
    Schinazi RF; Nahmias AJ
    Am J Med; 1982 Jul; 73(1A):40-8. PubMed ID: 6285731
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Single nucleotide polymorphisms of thymidine kinase and DNA polymerase genes in clinical herpes simplex virus type 1 isolates associated with different resistance phenotypes.
    Schubert A; Gentner E; Bohn K; Schwarz M; Mertens T; Sauerbrei A
    Antiviral Res; 2014 Jul; 107():16-22. PubMed ID: 24747042
    [TBL] [Abstract][Full Text] [Related]  

  • 26. (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU).
    De Clercq E
    Med Res Rev; 2005 Jan; 25(1):1-20. PubMed ID: 15389733
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantification of uptake and clearance of acyclovir in skin layers.
    Nair AB
    Antivir Ther; 2016; 21(1):17-25. PubMed ID: 26046929
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Methotrexate potentiates anti-herpes simplex virus type 1 activity of E-5-(2-bromovinyl)-2'-deoxyuridine.
    Pancheva SN
    Acta Virol; 1995 Apr; 39(2):117-9. PubMed ID: 7676937
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Topical cream-based oxyresveratrol in the treatment of cutaneous HSV-1 infection in mice.
    Lipipun V; Sasivimolphan P; Yoshida Y; Daikoku T; Sritularak B; Ritthidej G; Likhitwitayawuid K; Pramyothin P; Hattori M; Shiraki K
    Antiviral Res; 2011 Aug; 91(2):154-60. PubMed ID: 21669230
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of (E)-5-(2-bromovinyl)-2'-deoxyuridine on replication of Epstein-Barr virus in human lymphoblastoid cell lines.
    Lin JC; Smith MC; Choi EI; De Clercq E; Verbruggen A; Pagano JS
    Antiviral Res; 1985; Suppl 1():121-6. PubMed ID: 3002251
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Topical iontophoresis of valaciclovir hydrochloride improves cutaneous aciclovir delivery.
    Abla N; Naik A; Guy RH; Kalia YN
    Pharm Res; 2006 Aug; 23(8):1842-9. PubMed ID: 16850271
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antiviral efficacies of famciclovir, valaciclovir, and brivudin in disseminated herpes simplex virus type 1 infection in mice.
    Wutzler P; Ulbricht A; Färber I
    Intervirology; 1997; 40(1):15-21. PubMed ID: 9268766
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative in vitro and in vivo cytotoxic activity of (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU) and its arabinosyl derivative, (E)-5-(2-bromovinyl)-1-beta-D-arabinofuranosyluracil (BVaraU), against tumor cells expressing either the Varicella zoster or the Herpes simplex virus thymidine kinase.
    Grignet-Debrus C; Cool V; Baudson N; Degrève B; Balzarini J; De Leval L; Debrus S; Velu T; Calberg-Bacq CM
    Cancer Gene Ther; 2000 Feb; 7(2):215-23. PubMed ID: 10770629
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibitory activity of (E)-5-(2-bromovinyl)-2'-deoxyuridine on the salmonid herpesviruses, Oncorhynchus masou virus (OMV) and Herpesvirus salmonis.
    Kimura T; Nishizawa T; Yoshimizu M; De Clercq E
    Microbiol Immunol; 1988; 32(1):57-65. PubMed ID: 3374404
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization and susceptibility to antiviral agents of herpes simplex virus type 1 containing a unique thymidine kinase gene with an amber codon between the first and the second initiation codons.
    Saijo M; Suzutani T; Mizuta K; Kurane I; Morikawa S
    Arch Virol; 2008; 153(2):303-14. PubMed ID: 18066636
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro percutaneous penetration of acyclovir from solvent systems and Carbopol 971-P hydrogels: influence of propylene glycol.
    Díez-Sales O; Garrigues TM; Herráez JV; Belda R; Martín-Villodre A; Herráez M
    J Pharm Sci; 2005 May; 94(5):1039-47. PubMed ID: 15793815
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral and topical treatment of experimental HSV-1 genital herpes with (E)-5-(2-bromovinyl)-2'-deoxyuridine.
    Sim IS
    J Antimicrob Chemother; 1984 Aug; 14 Suppl A():111-8. PubMed ID: 6541647
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased sensitivity of thymidine kinase-deficient (TK-) tumor cell lines to the cell growth inhibitory effects of (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU) and related compounds.
    Balzarini J; De Clercq E; Verbruggen A; Crumpacker C; Ayusawa D; Seno T
    Anticancer Res; 1986; 6(5):1077-84. PubMed ID: 2432829
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of topical treatment for herpes simplex virus infections: predictions from an index of drug characteristics in vitro.
    Freeman DJ; Spruance SL
    J Infect Dis; 1986 Jan; 153(1):64-70. PubMed ID: 3079810
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of 1-dodecylazacycloheptan-2-one (Azone) on the topical therapy of cutaneous herpes simplex virus type 1 infection in hairless mice with 2',3'-di-O-acetyl-9-beta-D-arabinofuranosyladenine and 5'-O-valeryl-9-beta-D-arabinofuranosyladenine.
    Shannon WM; Westbrook L; Higuchi WI; Sugibayashi K; Baker DC; Kumar SD; Fox JL; Flynn GL; Ho NF; Vaidyanathan R
    J Pharm Sci; 1985 Nov; 74(11):1157-61. PubMed ID: 4087174
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.